CN Patent

CN107513057A — 一类乐伐替尼的乏氧活化前药及其应用

Assigned to Nanjing Medical University · Expires 2017-12-26 · 8y expired

What this patent protects

一类乐伐替尼的乏氧活化前药及其应用，结构符合通式(I) 其中：R为‑O‑、‑S‑。该类药物在正常条件下稳定，药效较弱。在乏氧条件下不稳定，能够产生具有更强药效的分子。该类药物具有良好的药效和安全性，可用于治疗肿瘤药物的制备。

USPTO Abstract

一类乐伐替尼的乏氧活化前药及其应用，结构符合通式(I) 其中：R为‑O‑、‑S‑。该类药物在正常条件下稳定，药效较弱。在乏氧条件下不稳定，能够产生具有更强药效的分子。该类药物具有良好的药效和安全性，可用于治疗肿瘤药物的制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN107513057A
Jurisdiction
CN
Classification
—
Expires
2017-12-26
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Medical University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.